Replenishment event in Lyon raises vital funds to tackle AIDS, tuberculosis and malaria, reaching US$ 14 billion target

Geneva, 10 October 2019 – Gavi, the Vaccine Alliance has congratulated The Global Fund to Fight AIDS, Tuberculosis and Malaria following a successful replenishment event in Lyon, France.

“I’d like to offer my warm congratulations to The Global Fund on their successful replenishment, as well as to the French government which played an instrumental role in making it such a success,” said Dr Seth Berkley, CEO of Gavi. “This new funding will help save millions of lives and give a vital boost to the international effort to end three of the world’s deadliest diseases. It also has a wider importance for global health, which depends on a well-funded, robust network of institutions like the Global Fund that combine to improve health systems and address bottle necks that stand in the way of healthier societies. I look forward to continuing the valuable work our two organisations do together.”

From joint investments and data sharing to common fiduciary mechanisms, Gavi collaborates with the Global Fund in the vast majority of Gavi-supported countries. For example, Gavi and The Global Fund worked together with 10 other health agencies to launch a new Global Action Plan for Healthy Lives and Well-Being for All at the UN General Assembly last month. In addition Gavi, the Global Fund and Unitaid are partnering to provide funding for the first phase of the RTS,S malaria vaccine pilot programme.

Gavi and the Global Fund have been sharing a joint headquarters at Geneva’s Global Health Campus since Summer 2018, enabling them to share support services, lower costs and foster collaboration between the two organisations.

Gavi’s own replenishment process for the 2021-25 period will culminate in a special event hosted by the UK government in summer 2020. The full investment opportunity is available here.

Notes to editors

About Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunise a whole generation – over 760 million children – and prevented more than 13 million deaths, helping to halve child mortality in 73 developing countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency. Learn more at and connect with us on Facebook and Twitter.

The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners. View the full list of donor governments and other leading organizations that fund Gavi’s work here.

Subscribe to our newsletter